Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29106785 | 1.00 | CA12 (0.43) | — | |
| Hydrochloric Acid SCHEMBL28284009 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL31513328 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL28138590 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL6025830 | 0.97 | — | — | |
| SCHEMBL2123718 | 0.96 | CA12 (0.45) | — | |
| SCHEMBL10001930 | 0.96 | CA12 (0.45) | — | |
| SCHEMBL20614479 | 0.96 | CA12 (0.45) | — | |
| SCHEMBL8136165 | 0.96 | — | — | |
| SCHEMBL4622 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1244 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116836371-B | Imidazole complex norbornene copolymer and preparation method and application thereof | ACADEMY OF NATIONAL FOOD AND STRATEGIC RESERVES ADMINISTRATION (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-120081881-A | Glutamic acid derivative, preparation method thereof and application thereof in rhythm gene regulation and antioxidation | 水羊化妆品制造有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-120040354-A | Telmisartan intermediate intermediate and preparation method thereof | 复星万邦(江苏)医药集团有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-116099010-B | Biocompatible tumorigenic iron-death magnetic resonance nano probe and preparation and application thereof | 天津医科大学第二医院 | 2025-04-15 | — | — | CN | claimed |
| CN-119548996-A | Reverse osmosis element repairing method | 万华化学集团股份有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-119455078-A | Borneol pain-relieving type scald repair hydrogel material and preparation method and application thereof | 西安科技大学 | 2025-02-18 | — | — | CN | claimed |
| CN-119371389-A | Small molecular compound for specific targeted lipid drop imaging and degradation and preparation method and application thereof | 四川大学华西医院 | 2025-01-28 | — | — | CN | claimed |
| CN-119371375-A | Preparation method of N-methylmorpholine | 石家庄合佳制药有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-119039047-A | High-weather-resistance cement brick and tile for archaize building and preparation method | 浙江华景通文旅科技有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-115372430-B | Carbon slurry for electrochemical test strip, preparation method of carbon slurry and electrochemical test strip | 湖南海源医疗科技股份有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-109224127-B | Self-assembled collagen stimulation microsphere with naturally-composed shell-core structure and preparation method thereof | 上海其胜生物制剂有限公司 | 2021-02-02 | — | — | CN | claimed |
| CN-108939941-B | A kind of PVDF flat-plate separation film with anticoagulant functions | 天津工业大学 | 2019-10-15 | — | — | CN | claimed |
| CN-107011339-A | Method and intermediate for the macrocyclic protease inhibitor for preparing HCV | 杨森制药公司 | 2017-08-04 | — | — | CN | claimed |
| US-8735598-B2 | Method for producing 1-biphenylmethylimidazole compound | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-05-27 | — | — | US | claimed |
| CN-102277737-A | Preparation method and application of polycaprolactone/natural high-molecular composite porous scaffold | — | 2011-12-14 | — | — | CN | claimed |
| CN-102083823-A | Method for producing 1-biphenylmethylimidazole compound | DAIICHI SANKYO CO LTD | 2011-06-01 | — | — | CN | claimed |
| US-20110092713-A1 | METHOD FOR PRODUCING 1-BIPHENYLMETHYLIMIDAZOLE COMPOUND | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2011-04-21 | — | — | US | claimed |
| EP-2298763-A1 | METHOD FOR PRODUCING 1-BIPHENYLMETHYLIMIDAZOLE COMPOUND | Daiichi Sankyo Company, Limited (JP) | 2011-03-23 | — | — | EP | claimed |
| CN-1042028-C | Morpholine derivative | YAMANOUCHI PHARMA CO LTD (JP) | 1999-02-10 | — | — | CN | claimed |
| CN-1117729-A | morpholine derivatives | YAMANOUCHI PHARMA CO LTD (JP) | 1996-02-28 | — | — | CN | claimed |